Search
for
Sort by
Research 421–450 of 876
- Current and future pharmacotherapy for alopecia areata
- Atlas of Geriatric Dermatology
- Selected topics in pediatric hair loss
- Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata
- The demographic and clinical profile of patients with alopecia areata in Syria: A study letter
- Janus Kinase inhibitors in dermatology: a review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Trichoscopic Findings of Frontal Fibrosing Alopecia
- Bitemporal alopecia areata
- Skin transcriptome reveals the Periodic changes in genes underlying hair follicle cycling in Cashmere goats
- Pharmacological Treatment of Alopecia
- Clinical Trials and Hair Loss
- Trichodystrophies: A hair-raising differential diagnosis
- Compounding as a Current Therapeutic Option in Dermatology
- Acne scars: Classification and treatment
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Utilization of a Combination of Papaya (Carica papaya L.) Seed Oil and Virgin Coconut Oil (VCO) in Pomade Formulation and Its Effectiveness Test
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- Lipid nanocarriers as innovative strategies for hair regrowth
- People’s experiences of eyebrow transplantation: A qualitative study
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Aesthetic medicine treatments for oncology patients — a narrative literature review
- Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis